Javascript must be enabled to continue!
Sputum quality affects assessment of airway microbiology in childhood asthma
View through CrossRef
Abstract
Background
The analysis of sputum is the principal basis for characterising lower airway microbiology in those with chronic respiratory conditions. For such analysis to be informative, samples that poorly reflect the lower airways must be identified and removed. Our cross-sectional study explored the relationship between the quality of sputum samples and their microbiological content. We further investigated the impact of excluding low quality samples on observed microbiota-disease relationships in childhood asthma.
Methods
Induced sputum was collected from children with or without asthma. Sputum quality was assessed according to squamous cell%, cell viability%, detection of sputum plugs, and salivary α-amylase levels. Sputum microbiota was characterised by 16S rRNA amplicon sequencing and qPCR.
Results
Of 170 participants, 130 had asthma. Between 19% (32/170) and 29% (53/170) of samples were deemed to be of insufficient quality, depending on the quality criterion applied. Stratification of samples based on any of the sputum quality cut-offs resulted in significant differences in microbiota characteristics (all p < 0.05), with salivary α-amylase the least discriminant between microbiota of acceptable and unacceptable samples. The removal of 53 poor-quality samples based on ≥ 30% squamous cells identified a difference in the sputum microbiota by asthma status (p = 0.017) that was not evident otherwise, including significantly higher levels of Haemophilus and Gemella in asthma samples.
Conclusions
Upper airway contamination of induced sputum samples from children is common. Exclusion of samples based on ≥ 30% squamous cells enables identification of asthma-airway microbiology relationships that are otherwise not apparent.
Springer Science and Business Media LLC
Title: Sputum quality affects assessment of airway microbiology in childhood asthma
Description:
Abstract
Background
The analysis of sputum is the principal basis for characterising lower airway microbiology in those with chronic respiratory conditions.
For such analysis to be informative, samples that poorly reflect the lower airways must be identified and removed.
Our cross-sectional study explored the relationship between the quality of sputum samples and their microbiological content.
We further investigated the impact of excluding low quality samples on observed microbiota-disease relationships in childhood asthma.
Methods
Induced sputum was collected from children with or without asthma.
Sputum quality was assessed according to squamous cell%, cell viability%, detection of sputum plugs, and salivary α-amylase levels.
Sputum microbiota was characterised by 16S rRNA amplicon sequencing and qPCR.
Results
Of 170 participants, 130 had asthma.
Between 19% (32/170) and 29% (53/170) of samples were deemed to be of insufficient quality, depending on the quality criterion applied.
Stratification of samples based on any of the sputum quality cut-offs resulted in significant differences in microbiota characteristics (all p < 0.
05), with salivary α-amylase the least discriminant between microbiota of acceptable and unacceptable samples.
The removal of 53 poor-quality samples based on ≥ 30% squamous cells identified a difference in the sputum microbiota by asthma status (p = 0.
017) that was not evident otherwise, including significantly higher levels of Haemophilus and Gemella in asthma samples.
Conclusions
Upper airway contamination of induced sputum samples from children is common.
Exclusion of samples based on ≥ 30% squamous cells enables identification of asthma-airway microbiology relationships that are otherwise not apparent.
Related Results
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Background:
Evaluation of induced sputum can be used to predict asthma severity or exacerbation
Resear...
Different expression levels of interleukin-35 in asthma phenotypes
Different expression levels of interleukin-35 in asthma phenotypes
Abstract
Background
Interleukin (IL)-35 is a newly discovered inhibitory cytokine which is produced by regulatory B and T lymphocytes and belongs to...
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
Asthma, a ubiquitous chronic respiratory ailment, stands as a formidable global health concern, affecting millions of individuals across the world. This widespread condition, marke...
Sputum periostin in patients with different asthma phenotypes
Sputum periostin in patients with different asthma phenotypes
Abstract
Background
Asthma is a common respiratory condition causing symptoms such as cough, chest tightness and wheezing that a...
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
Background/objectives: The association between adverse childhood experiences (ACEs) and asthma severity among United States (US) adults with asthma has not been well documented. In...
Prevalence of Comorbidities among United States Adults with asthma and Their Association with Asthma Severity
Prevalence of Comorbidities among United States Adults with asthma and Their Association with Asthma Severity
Abstract
Introduction
The burden of comorbidities in asthma patients significantly affects management strategies and outcomes. ...

